PCN302 - IS THE NEW NICE APPRAISAL PROCESS FOR ONCOLOGY INDICATIONS TOO POSITIVE IN ITS ASSESSMENT OF CANCER DRUGS IN ENGLAND?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.384
https://www.valueinhealthjournal.com/article/S1098-3015(18)33684-2/fulltext
Title :
PCN302 - IS THE NEW NICE APPRAISAL PROCESS FOR ONCOLOGY INDICATIONS TOO POSITIVE IN ITS ASSESSMENT OF CANCER DRUGS IN ENGLAND?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33684-2&doi=10.1016/j.jval.2018.09.384
First page :
Section Title :
Open access? :
No
Section Order :
2286